CORT — CORCEPT THERAPEUTICS INC

Ownership history in Birchview Capital, LP  ·  41 quarters on record

This page tracks every 13F SEC filing in which Birchview Capital, LP reported a position in CORCEPT THERAPEUTICS INC (CORT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
6.55% (2025 Q1)
Avg. % of fund
1.15%
First filed
2015 Q4
Last filed
2025 Q4
Quarters held
41
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 67,200 — 0% 1.37% $2.3M $34.80
2025 Q3 UNCHANGED 67,200 — 0% 4.22% $5.6M $83.11
2025 Q2 ADDED 67,200 +1,200 +1.8% 4.90% $4.9M $73.40
2025 Q1 REDUCED 66,000 -8,000 -10.8% 6.55% $7.5M $114.22
37 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CORT price (monthly, adj. close)

Other funds also holding CORT

As of 2025 Q4 — sorted by position size

INGALLS & SNYDER LLC 3Y 7Y 9.19% TANAKA CAPITAL MANAGEMENT INC 3Y 7Y 7.05% Checkpoint Capital L.P. 4.36% Parallel Advisors, LLC 3Y 7Y 2.47% Checkpoint Capital L.P. 1.39% S&T BANK/PA 3Y 7Y 1.03% Intrinsic Edge Capital Management LLC 3Y 7Y 0.86% Newtyn Management, LLC 3Y 7Y 0.73% FAS Wealth Partners, Inc. 3Y 7Y 0.7% Ikarian Capital, LLC 3Y 0.64%
← Back to Birchview Capital, LP Holdings